MRK vs RMD
By Alex · Tickerpine
Merck & Co., Inc. vs ResMed Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | RMD |
|---|---|---|
| Price | $128.66 | $200.29 |
| Market cap | $317.77B | $29.05B |
| P/E ratio | 36.2 | 19.3 |
| ROE | 18.94% | 25.25% |
| Profit margin | 13.59% | 27.44% |
| Revenue growth | 4.90% | 10.80% |
| Dividend yield | 2.64% | 1.20% |
| Beta | 0.22 | 0.78 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs RMD in plain English
- MRK is the bigger company — about 10.9× the market cap of RMD.
- RMD is cheaper on earnings (P/E 19.3 vs 36.2).
- RMD earns a higher return on equity (25% vs 19%).
- RMD is growing revenue faster (11% vs 5%).
- MRK has the higher dividend yield (2.64% vs 1.20%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
RMD return calculator
See what $1,000 in ResMed Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.